Barclays’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-100
| Closed | – | – | 4515 |
|
|
2024
Q3 | $0 | Buy |
+100
| New | – | ﹤0.01% | 4460 |
|
|
2020
Q3 | – | Sell |
-1,748
| Closed | -$219K | – | 3934 |
|
|
2020
Q2 | $219K | Buy |
1,748
+1,446
| +479% | +$181K | ﹤0.01% | 2762 |
|
|
2020
Q1 | $59K | Buy |
302
+83
| +38% | +$16.2K | ﹤0.01% | 3028 |
|
|
2019
Q4 | $73K | Buy |
219
+109
| +99% | +$36.3K | ﹤0.01% | 3518 |
|
|
2019
Q3 | $35K | Sell |
110
-34
| -24% | -$10.8K | ﹤0.01% | 3767 |
|
|
2019
Q2 | $62K | Buy |
144
+98
| +213% | +$42.2K | ﹤0.01% | 3779 |
|
|
2019
Q1 | $27K | Buy |
46
+42
| +1,050% | +$24.7K | ﹤0.01% | 3848 |
|
|
2018
Q4 | $1K | Sell |
4
-49
| -92% | -$12.3K | ﹤0.01% | 4034 |
|
|
2018
Q3 | $37K | Buy |
53
+44
| +489% | +$30.7K | ﹤0.01% | 3821 |
|
|
2018
Q2 | $5K | Sell |
9
-9
| -50% | -$5K | ﹤0.01% | 4003 |
|
|
2018
Q1 | $50K | Buy |
+18
| New | +$50K | ﹤0.01% | 3510 |
|